[1]
Chandra, S.; Alam, M.T.; Dey, J.Pulikkaparambil; Sasidharan, B.C.; Ray, U.; Srivastava, A.K.; Gandhi, S.; Tripathi, P.P. Healthy gut, healthy brain: the gut microbiome in neurodegenerative disorders. Curr. Top. Med. Chem., 2020, 20(13), 1142-1153.
[2]
Datta, A.; Sarmah, D.; Kalia, K.; Borah, A.; Wang, X.; Dave, K.R.; Yavagal, D.R.; Bhattacharya, P. Advances in studies on stroke-induced secondary neurodegeneration (SND) and its treatment. Curr. Top. Med. Chem., 2020, 20(13), 1154-1168.
[3]
Maan, G.; Sikdar, B.; Kumar, A.; Shukla, R.; Mishra, A. Role of flavonoids in neurodegenerative diseases: limitations and future perspectives. Curr. Top. Med. Chem., 2020, 20(13), 1169-1194.
Current Topics in Medicinal Chemistry
Title:Advances in Studies on Neurodegenerative Diseases and their Treatments
Volume: 20 Issue: 13
Author(s): Satya P. Gupta
Affiliation:
Export Options
About this article
Cite this article as:
Gupta P. Satya , Advances in Studies on Neurodegenerative Diseases and their Treatments, Current Topics in Medicinal Chemistry 2020; 20 (13) . https://dx.doi.org/10.2174/156802662013200519075027
DOI https://dx.doi.org/10.2174/156802662013200519075027 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
9
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
β-Lactams as Neuroprotective Agents
Anti-Infective Agents in Medicinal Chemistry Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy
Current Alzheimer Research Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype
Current Gene Therapy The Current View on the Helicase Activity of RNA Helicase A and Its Role in Gene Expression
Current Protein & Peptide Science Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy An Update in the Management of Obesity: The Weight of CNS Targets
Recent Patents on CNS Drug Discovery (Discontinued) Molecular Docking Studies of Methamphetamine and Amphetamine- Related Derivatives as an Inhibitor against Dopamine Receptor
Current Computer-Aided Drug Design Reversible and Irreversible Aggregation of Proteins from the FET Family: Influence of Repeats in Protein Chain on Its Aggregation Capacity
Current Protein & Peptide Science Targeting Neurotrophin Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Neurodegenerative Disorders and Cholesterol
Current Alzheimer Research Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
Reviews on Recent Clinical Trials Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease
Current Drug Metabolism Cyclooxygenase-2 Biology
Current Pharmaceutical Design Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Current Alzheimer Research Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Computational Approaches to Screen Candidate Ligands with Anti- Parkinson’s Activity Using R Programming
Current Topics in Medicinal Chemistry RNAi Applications in Therapy Development for Neurodegenerative Disease
Current Pharmaceutical Design Meet Our Section Editor:
Current Pharmaceutical Biotechnology Diabetes, Hyperglycemia and Accelerated Atherosclerosis: Evidence Supporting a Role for Endoplasmic Reticulum (ER) Stress Signaling
Cardiovascular & Hematological Disorders-Drug Targets